scholarly journals Erratum To: Abstract of the 20th International Anniversary MASCC/ISOO Symposium: A Phase III randomized double-blind placebo controlled clinical trial to determine the efficacy of low level laser therapy for the prevention of oral mucositis in patients undergoing hematopoietic cell transplantation

2007 ◽  
Vol 15 (11) ◽  
pp. 1331-1332
Author(s):  
M. M. Schubert ◽  
F. P. Eduardo ◽  
K. A. Guthrie ◽  
J. C. Franquin ◽  
R. J. Bensadoun ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Laser Therapy ◽  
Cell Transplantation ◽  
Hematopoietic Cell Transplantation ◽  
Phase Iii ◽  
Low Level Laser Therapy ◽  
Controlled Clinical Trial ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Level Laser

Doppelblinde, randomisierte, placebokontrollierte Low-Level-Laser Therapiestudie bei Patienten mit primärem Raynaudphänomen

VASA ◽  
2002 ◽  
Vol 31 (2) ◽  
pp. 91-94 ◽  
Author(s):  
Hirschl ◽  
Katzenschlager ◽  
Ammer ◽  
Melnizky ◽  
Rathkolb ◽  
...  
Keyword(s):  
Laser Therapy ◽  
Raynaud’S Phenomenon ◽  
Raynaud's Phenomenon ◽  
Low Level Laser Therapy ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Low Level ◽  
Low Level Laser ◽  
Level Laser ◽  
Primary Raynaud’S Phenomenon

Background: No causal treatment of primary Raynaud’s phenomenon is available due to its unclear aetiology. Low level laser therapy (LLLT) is applied in a multitude of medical conditions often without sufficient evidence of efficacy and established mechanisms. To asses the effect of this therapy in patients with primary Raynaud’s phenomenon a randomised, double blind, placebo controlled cross over study was designed. Patients and methods: Absolute and relative frequency and intensity of vasospastic attacks during three weeks of either LLLT or placebo therapy and results of infrared thermography before onset and at the end of both therapy sequences were evaluated in 15 patients with primary Raynaud’s phenomenon. Results: Frequency of Raynaud’s attacks was not significantly affected by low level laser therapy. Compared to placebo a significantly lower intensity of attacks during laser irradiation was observed, but no transfer effect occurred. Additionally the mean temperature gradient after cold exposure was reduced after laser irradiation, while the number of fingers showing prolonged rewarming was unaffected. Conclusion: Though further studies are necessary to confirm these results we could demonstrate for the first time in a double blind placebo controlled clinical trial that low laser therapy is a potential candidate for an effective therapy of Raynaud`s phenomenon, although effects seem to be of short duration.

Can low-level laser therapy (LLLT) associated with an aerobic plus resistance training change the cardiometabolic risk in obese women? A placebo-controlled clinical trial

2015 ◽  
Vol 153 ◽  
pp. 103-110 ◽  
Author(s):  
Fernanda Oliveira Duarte ◽  
Marcela Sene-Fiorese ◽  
Antonio Eduardo de Aquino Junior ◽  
Raquel Munhoz da Silveira Campos ◽  
Deborah Cristina Landi Masquio ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Resistance Training ◽  
Laser Therapy ◽  
Cardiometabolic Risk ◽  
Low Level Laser Therapy ◽  
Controlled Clinical Trial ◽  
Obese Women ◽  
Low Level ◽  
Low Level Laser ◽  
Level Laser

scholarly journals SHORT-TERM EFFICACY OF LOW-LEVEL LASER THERAPY IN PATIENTS WITH KNEE OSTEOARTHRITIS: A RANDOMIZED PLACEBO-CONTROLLED, DOUBLE-BLIND CLINICAL TRIAL

2011 ◽  
Vol 46 (5) ◽  
pp. 526-533 ◽  
Author(s):  
Vanessa Ovanessian Fukuda ◽  
Thiago Yukio Fukuda ◽  
Márcio Guimarães ◽  
Silvia Shiwa ◽  
Bianca Del Cor de Lima ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Knee Osteoarthritis ◽  
Laser Therapy ◽  
Low Level Laser Therapy ◽  
Short Term ◽  
Double Blind ◽  
Low Level ◽  
Low Level Laser ◽  
Level Laser ◽  
Double Blind Clinical Trial
Sign in / Sign up

Export Citation Format

Share Document